Revvity, Inc. (RVTY)
Health Care – LABORATORY ANALYTICAL INSTRUMENTS
- Headquarters
- United States
- Employees
- 11,000
- Market Cap
- $12.8B
About Revvity, Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
SentiSense also tracks daily options readings for Revvity, Inc.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Revvity, Inc. stock analysis, sentiment tracking, and market intelligence on SentiSense.